Ionis Pharmaceuticals (IONS) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Ionis Pharmaceuticals (IONS)

An SI Board Since May 1996

Posts	SubjectMarks	Bans	Symbol
4676	121	0	IONS

Emcee: Keith Fauci	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
3326	Thanks, yes, I would expect leaks from an open label trial. We discussed this l	tuck	-	12/6/2002
3325	The trial is open label I believe, so his conclusion is probably right. I don	Elmer	-	12/6/2002
3324	Ah, here's the beef from the UBS guy: thestreet.com Apparently believes Af	tuck	-	12/6/2002
3323	<Tempted to add more in the low 6's here.> The current price reminds m	Elmer	-	12/6/2002
3322	I think oral delivery of antisense compounds is important in the long run becaus	tuck	-	12/6/2002
3321	how important, may i ask is that orasense JV to ISIS overall antisense franchise	bob zagorin	-	12/6/2002
3320	One thing that has not been mentioned here recently is that the OraSense JV with	tuck	-	12/6/2002
3319	unfortunately, i added twice in the last week but i'm a long term believer i	bob zagorin	-	12/6/2002
3318	Tuck I added some yesterday at 7.96 and thought I got a bargain. Tempted to add	Findit	-	12/6/2002
3317	No reasons given: >>11:55AM ISIS Pharm cut to Reduce at UBS; target $6 (I	tuck	-	12/6/2002
3316	Down over a buck to the 6.75 area. What's going on? Thanks. Jim	Findit	-	12/6/2002
3315	yes, 14 days to cover now at average daily volume of about 1/2 m. if they do hav	bob zagorin	-	12/3/2002
3314	Tuck et al--One source of short selling may come from the $125 Million Converti	JOEBT1	-	12/2/2002
3313	>>Gut 2002 Jul;51(1):30-6 Double blind, pla	tuck	-	12/2/2002
3312	I'm about to go flying, and don't have time to think about these, so wil	tuck	-	12/2/2002
3311	Thanks Tuck. Think I will pick up some more if it goes to the 7.50 area. It se	Findit	-	12/2/2002
3310	my guess also is that it is elan related. i have emailed IR and will post if i g	bob zagorin	-	12/2/2002
3309	My guesses are one, that some folks thought 2302 was dead. It has failed once i	tuck	-	12/2/2002
3308	Anyone with a guess on why the price of ISIS is dropping fast. Now at 7.91. Th	Findit	-	12/2/2002
3307	>>CARLSBAD, Calif., Nov. 21 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals	tuck	-	11/21/2002
3306	Coverage Reiterated Company Symbol Brokerage Firm Reiterated Rating: Target IS	bob zagorin	-	11/13/2002
3305	New Data on Capsule Form of ISIS 104838 Demonstrate Antisense Drugs Can Be Admin	bob zagorin	-	11/12/2002
3304	DOW JONES NEWSWIRES Rating reiterations for Nov. 6 from Briefing.com: Company	bob zagorin	-	11/7/2002
3303	<pre> ISIS PHARMACEUTICALS, INC. SELECTED FINANCIA	SemiBull	-	11/6/2002
3302	Isis Pharmaceuticals Reports Third Quarter And Year-To-Date 2002 Financial Resul	bob zagorin	-	11/6/2002

Go to reply# or date (mm/dd/yy):